Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
lung disease
Pharma
Insmed plots key expansion for Arikayce on new data
Insmed has revealed results from a trial of Arikayce, which could pave the way for a significant label expansion for the lung disease drug.
Kevin Dunleavy
Mar 23, 2026 11:21am
BI's Jascayd quickly expands lung disease reach with new FDA nod
Dec 22, 2025 12:02pm
Boehringer breaks IPF treatment drought with new FDA approval
Oct 8, 2025 8:56am
United shares surge on Tyvaso win in new lung disease population
Sep 2, 2025 3:34pm
Insmed's Brinsupri nabs landmark FDA nod in chronic lung disease
Aug 12, 2025 12:05pm
Boehringer backs drive to improve bronchiectasis management
Jul 2, 2025 9:23am
